Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Song Hh is active.

Publication


Featured researches published by Song Hh.


International Journal of Nanomedicine | 2012

Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance

Yanyan Ren; Haijun Zhang; Baoan Chen; Jian Cheng; Xiaohui Cai; Ran Liu; Guohua Xia; Weiwei Wu; Shuai Wang; Ding Jh; Chong Gao; Jun Wang; Wen Bao; Lei Wang; Liang Tian; Song Hh; Xuemei Wang

Background Multidrug resistance in cancer is a major obstacle for clinical therapeutics, and is the reason for 90% of treatment failures. This study investigated the efficiency of novel multifunctional Fe3O4 magnetic nanoparticles (Fe3O4-MNP) combined with chemotherapy and hyperthermia for overcoming multidrug resistance in an in vivo model of leukemia. Methods Nude mice with tumor xenografts were randomly divided into a control group, and the treatment groups were allocated to receive daunorubicin, 5-bromotetrandrine (5-BrTet) and daunorubicin, Fe3O4-MNP, and Fe3O4-MNP coloaded with daunorubicin and 5-bromotetrandrine (Fe3O4-MNP-DNR-5-BrTet), with hyperthermia in an alternating magnetic field. We investigated tumor volume and pathology, as well as P-glycoprotein, Bcl-2, Bax, and caspase-3 protein expression to elucidate the effect of multimodal treatment on overcoming multidrug resistance. Results Fe3O4-MNP played a role in increasing tumor temperature during hyperthermia. Tumors became significantly smaller, and apoptosis of cells was observed in both the Fe3O4-MNP and Fe3O4-MNP-DNR-5-BrTet groups, especially in the Fe3O4-MNP-DNR-5-BrTet group, while tumor volumes in the other groups had increased after treatment for 12 days. Furthermore, Fe3O4-MNP-DNR-5-BrTet with hyperthermia noticeably decreased P-glycoprotein and Bcl-2 expression, and markedly increased Bax and caspase-3 expression. Conclusion Fe3O4-MNP-DNR-5-BrTet with hyperthermia may be a potential approach for reversal of multidrug resistance in the treatment of leukemia.


International Journal of Nanomedicine | 2009

Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.

Jian Cheng; Weiwei Wu; Baoan Chen; Feng Gao; Xu Wl; Chong Gao; Ding Jh; Yun-Yu Sun; Song Hh; Wen Bao; Xin-chen Sun; Cui-Rong Xu; Wen-ji Chen; Ning-Na Chen; Li-jie Liu; Guohua Xia; Xiaomao Li; Xuemei Wang

This study aims to evaluate the multidrug resistance (MDR) reversal activity by magnetic nanoparticles of Fe3O4 (MNPs-Fe3O4) and 5-bromotetrandrine (BrTet) MDR cell line K562/A02 solitarily or symphysially. The proliferation of K562 and K562/A02 cells and the cytotoxicity on peripheral blood mononuclear cells (PMBCs) were evaluated by MTT assay. Cellular accumulation of daunorubicin (DNR) was analyzed by flow cytometry. Real-time polymerase chain reaction and Western blotting analyses were performed to examine the mRNA and protein levels of mdr1, respectively. The results showed that the combination of MNPs-Fe3O4 and BrTet with effective concentrations significantly increased cytotoxicity against MDR cell line K562/A02. Both BrTet and MNPs-Fe3O4 increased the intracellular DNR accumulation in the K562/A02 cell line, and downregulated the level of mdr1 gene and expression of P-glycoprotein. Furthermore, the combination did not have significant cytotoxicity in PMBCs. We propose that MNPs-Fe3O4 conjugated with DNR and BrTet probably have synergetic effects on MDR reversal.


International Journal of Nanomedicine | 2012

Effect of magnetic nanoparticles of Fe3O4 and wogonin on the reversal of multidrug resistance in K562/A02 cell line

Jian Cheng; Lin Cheng; Baoan Chen; Guohua Xia; Chong Gao; Song Hh; Wen Bao; Qinglong Guo; Haiwei Zhang; Xuemei Wang

Background Multidrug resistance is the main obstacle to the efficiency of systemic chemotherapy against hematologic malignancy. This study investigated the reversible effect of the copolymer wogonin and daunorubicin coloaded into Fe3O4 magnetic nanoparticles, and the mechanism potentially involved. Methods The growth inhibition rate of K562/A02 cells was investigated by MTT assay, and apoptosis of cells and the intracellular daunorubicin concentration were detected by flow cytometry. Distribution of nanoparticles taken up by K562/A02 cells was observed under a transmission electron microscope and demonstrated by Prussian blue staining. The transcription level of MDR1 mRNA and expression of P-glycoprotein were determined by reverse transcriptase polymerase chain reaction and Western blotting assay, respectively. Results The reversible effect of daunorubicin-wogonin magnetic nanoparticles was 8.87-fold that of daunorubicin + wogonin and of daunorubicin magnetic nanoparticles. Transmission electron microscopy and Prussian blue staining revealed that the nanoparticles were located in the endosome vesicles of cytoplasm. Also, the apoptosis rate and accumulation of intracellular daunorubicin in the daunorubicin-wogonin magnetic nanoparticle group were significantly higher than that in the daunorubicin, daunorubicin + wogonin, and daunorubicin magnetic nanoparticle groups. Furthermore, transcription of MDR1 mRNA and expression of P-glycoprotein in K562/A02 cells were significantly downregulated in the daunorubicin-wogonin magnetic nanoparticle group compared with the other groups. Conclusion These findings suggest that the remarkable effects of the novel daunorubicin-wogonin magnetic nanoparticle formulation on multidrug resistant K562/A02 leukemia cells would be a promising strategy for overcoming multidrug resistance.


Patient Preference and Adherence | 2014

Clinical outcomes of transfusion-associated iron overload in patients with refractory chronic anemia.

Chong Gao; Li Li; Baoan Chen; Song Hh; Jian Cheng; Xiaoping Zhang; Yunyu Sun

Background The purpose of this study was to evaluate the clinical outcomes of transfusion-associated iron overload in patients with chronic refractory anemia. Methods Clinical manifestations, main organ function, results of computed tomography (CT), endocrine evaluation, and serum ferritin levels were analyzed retrospectively in 13 patients who were transfusion-dependent for more than 1 year (receiving >50 units of red blood cells) to determine the degree of iron overload and efficacy of iron-chelating therapy. Results Serum ferritin levels increased to 1,830–5,740 ng/mL in all patients. Ten patients had abnormal liver function. The CT Hounsfield units in the liver increased significantly in eleven patients, and were proportional to their serum ferritin levels. Skin pigmentation, liver dysfunction, and endocrine dysfunction were observed in nine patients with serum ferritin >3,500 ng/mL, eight of whom have since died. Interestingly, serum ferritin levels did not decrease significantly in nine transfusion-dependent patients who had received 15–60 days of iron-chelating therapy. Conclusion Transfusion-dependent patients may progress to secondary iron overload with organ impairment, which may be fatal in those who are heavily iron-overloaded. The CT Hounsfield unit is a sensitive indicator of iron overload in the liver. Iron chelation therapy should be initiated when serum ferritin is >1,000 ng/mL and continued until it is <1,000 ng/mL in transfusional iron-overloaded patients.


Cell Transplantation | 2011

Effect of splenectomy on pancytopenia after a peripheral blood stem cell transplantation.

Ding Jh; Wen Bao; Jun Wang; Gang Zhao; Jian Chen; Song Hh

To analyze the effect of a splenectomy on pancytopenia after a peripheral blood stem cell transplantation (PBSCT) in chronic myeloid leukemia (CML) patients. Three CML patients diagnosed with splenomegaly in our department from 2002 to 2006 received a splenectomy after PBSCT. Patient 1, a 42-year-old male in chronic phase (CP), received an HLA-identical sibling allo-PBSCT. Patient 2, a 28-year-old female in aggressive phase (AP), received a PBSCT from her twin. Patient 3, a 26-year-old male in chronic phase (CP), received a PBSCT from an unrelated donor. The conditioning regimen included busulfan and cyclophosphamide (BU/CY2). Patients 1, 2, and 3 received splenectomies on days 168, 51, and 114, respectively. Bcr-abl transcripts were detected using the polymerase chain reaction (PCR). Chimerism was documented by PCR amplification of a variable number of tandem repeat (VNTR) polymorphrisms. Neither metrisone (2 mg/kg/day for 7 days), mycophenolic acid (MMF) (0.5 g twice daily for 1 month), high-dose γ-globulin (0.4 g/kg/day for 5 days), granulocyte colony-stimulating factor (G-CSF) therapy, nor erythropoietin (EPO) therapy had produced post-PBSCT hematopoiesis recovery. Patients 1 and 2 had 5% Ph-positive chromosomes while patient 3 exhibited graft-versus-host disease (GVHD). After receiving the splenectomy, all three had a rapid hematopoeitic recovery with no evidence of Ph-positive chromosomes, and patients 1 and 3 showed complete donor chimerism (CDC). Patient 1 developed chronic GVHD (cGVHD) on day 210 postsplenectomy that was treated successfully with prednisone. Patient 2 had acute GVHD on day 55 that was treated successfully with dexamethasone (10 mg), administered intravenously once a day for 3 days with good clinical response. To date, patients 1, 2, and 3 have survived postprocedure for 85, 49, and 25 months, respectively. Splenectomy is an effective option for the patients who have pancytopenia after PBSCT and the patients recovered a good graft function after splenectomy without procedure-related complication and with long-time survival. GVHD can develop in both allo-PBSCT and syngeneic PBSCT. A splenectomy after PBSCT may increase the risk of GVHD, enhance the effect of graft versus leukemia (GVL), promote CDC formation.


Journal of Experimental Hematology | 2008

[Effect of tetrandrine, toremifene and their combination on the reversion of multidrug resistance of K562/A02 cell line].

Zhao Qx; Chen Ba; Jian Cheng; Ding Jh; Feng Gao; Gao C; Sun Yy; Jun Wang; Zhao G; Bao W; Song Hh


Journal of Experimental Hematology | 2007

[Effects of platelet-derived membrane microparticles on angiogenesis in chick chorioallantoic membranes].

Chen Ba; Zhong Yj; Huang Cy; Li Cp; Shi Gy; Xiao Jy; Tang Rc; Ding Jh; Gao C; Sun Yy; Jian Cheng; Jun Wang; Zhao G; Ma Y; Song Hh; Fei F; Pei Xp


Journal of Experimental Hematology | 2010

[Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines].

Wang F; Chen Ba; Jian Cheng; Xu Wl; Wang Xm; Ding Jh; Gao C; Sun Yy; Jun Wang; Zhao G; Bao W; Song Hh; Feng Gao; Zhang W; Guohua Xia; Pei Xp; Wu Ww; Yin L; Shan Xy


Journal of Experimental Hematology | 2008

Sodium valproate synergizes adriamycin to inhibit proliferation and induce apoptosis in myelodysplastic syndrome cell line

Yu C; Chen Ba; Gao C; Ding Jh; Guohua Xia; Shao Zy; Feng Gao; Sun Yy; Jian Cheng; Zhao G; Jun Wang; Song Hh; Ma Y; Bao W


Blood | 2014

The New Targeted Nanoparticles: Tf-Peg-PLL-PLGA Combined with Daunorubicin Overcome Hypoxia Induced Drug Resistance of K562 Cells

Ping Liu; Liting Guo; Fei Wang; Guohua Xia; Yonglu Wang; Xueming Li; Song Hh; Wei Chen; Haixiang Yin; Baoan Chen

Collaboration


Dive into the Song Hh's collaboration.

Top Co-Authors

Avatar

Ding Jh

Southeast University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Feng Gao

Southeast University

View shared research outputs
Top Co-Authors

Avatar

Chen Ba

Southeast University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wen Bao

Southeast University

View shared research outputs
Top Co-Authors

Avatar

Jun Wang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Bao W

Jiangsu University

View shared research outputs
Top Co-Authors

Avatar

Jun Wang

Chinese Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Xu Wl

Southeast University

View shared research outputs
Researchain Logo
Decentralizing Knowledge